Autophagy: From basic science to clinical application

Mucosal Immunology

Volumn 2, Issue 4, 2009, Pages 315-330

  Van Limbergen, Johan ^a,b   Stevens, C ^a   Nimmo, E R ^a   Wilson, D C ^a,b   Satsangi, J ^a  

^a UNIVERSITY OF EDINBURGH   (United Kingdom)

^b ROYAL HOSPITAL FOR SICK CHILDREN   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; AUTOPHAGY RELATED 16 LIKE 1 PROTEIN; AUTOPHAGY RELATED PROTEIN; BECLIN 1; CELL PROTEIN; EVEROLIMUS; HAMARTIN; IMMUNITY RELATED P47 GUANOSINE TRIPHOSPHATASE; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LEUCINE RICH REPEAT KINASE 2; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PROTEIN BCL 2; PROTEIN LC3; PROTEIN P62; PROTEIN VPS34; RAPAMYCIN; REACTIVE OXYGEN METABOLITE; SMALL MOLECULE ENHANCER OF RAPAMYCIN; TOLL LIKE RECEPTOR; TUBERIN; UNCLASSIFIED DRUG; X BOX BINDING PROTEIN 1;

ADAPTIVE IMMUNITY; ALZHEIMER DISEASE; ANTIGEN PRESENTATION; APOPTOSIS; AUTOPHAGY; BACTERIAL IMMUNITY; CANCER GROWTH; CANCER INHIBITION; CELL FUNCTION; COLITIS; CROHN DISEASE; DEGENERATIVE DISEASE; DRUG MECHANISM; ENDOPLASMIC RETICULUM STRESS; ENTERITIS; ENZYME INHIBITION; HUMAN; HUNTINGTON CHOREA; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; INNATE IMMUNITY; MALIGNANT NEOPLASTIC DISEASE; MOLECULAR DYNAMICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN PROTEIN INTERACTION; PROTEIN TRANSPORT; REGULATORY MECHANISM; REVIEW; SIGNAL TRANSDUCTION; VIRUS IMMUNITY;

EID: 67649295476     PISSN: 19330219     EISSN: None     Source Type: Journal    
DOI: 10.1038/mi.2009.20     Document Type: Review

References (179)

1. Levine, B. & Deretic, V. Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol. 7, 767-777 (2007 ).
2. Xie, Z. & Klionsky, D. J. Autophagosome formation: Core machinery and adaptations. Nat. Cell. Biol. 9, 1102-1109 (2007).
3. Kim, J., Huang, W-P., Stromhaug, P. E. & Klionsky, D. J. Convergence of multiple autophagy and cytoplasm to vacuole targeting components to a perivacuolar membrane compartment prior to de novo vesicle formation. J. Biol. Chem. 277, 763-773 (2002).
4. Suzuki, K. The pre-autophagosomal structure organized by concerted functions of APG genes is essential for autophagosome formation. EMBO J. 20, 5971-5981 (2001).
5. Mizushima, N. Dissection of autophagosome formation using Apg5-deficient mouse embryonic stem cells. J. Cell Biol. 152, 657-668 (2001).
6. Mizushima, N. et al. Mouse Apg16L, a novel WD-repeat protein, targets to the autophagic isolation membrane with the Apg12-Apg5 conjugate. J. Cell Sci. 116, 1679-1688 (2003).
7. Kirisako, T. et al. Formation process of autophagosome is traced with Apg8/Aut7p in yeast. J. Cell Biol. 147, 435-446 (1999 ).
8. Itoh, T., Fujita, N., Kanno, E., Yamamoto, A., Yoshimori, T. & Fukuda, M. Golgi-resident small GTPase Rab33B interacts with Atg16L and modulates autophagosome formation. Mol. Biol. Cell. 19, 2916-2925 (2008).
9. Fujita, N., Itoh, T., Omori, H., Fukuda, M., Noda, T. & Yoshimori, T. The Atg16L complex specifies the site of LC3 lipidation for membrane biogenesis in autophagy. Mol. Biol. Cell 19, 2092-2100 (2008).
10. Delgado, M. et al. Autophagy and pattern recognition receptors in innate immunity. Immunol. Rev. 227, 189-202 (2009).
11. Kabeya, Y. LC3, a mammalian homologue of yeast Apg8p, is localized in autophagosome membranes after processing. EMBO J. 19, 5720-5728 (2000).
12. Yorimitsu, T. & Klionsky, D. J. Autophagy: Molecular machinery for self-eating. Cell Death Differ. 12 (Suppl 2), 1542-1552 (2005).
13. Klionsky, D. J. et al. Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy 4, 151-175 (2008).
14. Mizushima, N. et al. A protein conjugation system essential for autophagy. Nature 395, 395-398 (1998).
15. Guan, J. et al. Cvt18/Gsa12 is required for cytoplasm-to-vacuole transport, pexophagy, and autophagy in Saccharomyces cerevisiae and Pichia pastoris. Mol. Biol. Cell 12, 3821-3838 (2001).
16. Baba, M., Osumi, M., Scott, S. V., Klionsky, D. J. & Ohsumi, Y. Two distinct pathways for targeting proteins from the cytoplasm to the vacuole/lysosome. J. Cell Biol. 139, 1687-1695 (1997).
17. Ogawa, M., Yoshimori, T., Suzuki, T., Sagara, H., Mizushima, N. & Sasakawa, C. Escape of intracellular Shigella from autophagy. Science 307, 727-731 (2005).
18. Shintani, T., Huang, W. P., Stromhaug, P. E. & Klionsky, D. J. Mechanism of cargo selection in the cytoplasm to vacuole targeting pathway. Dev. Cell 3, 825-837 (2002).
19. Sanjuan, M. A. et al. Toll-like receptor signalling in macrophages links the autophagy pathway to phagocytosis. Nature 450, 1253-1257 (2007).
20. Pankiv, S. et al. p62/SQSTM1 binds directly to Atg8/LC3 to facilitate degradation of ubiquitinated protein aggregates by autophagy. J. Biol. Chem. 282, 24131-24145 (2007).
21. Munz, C. Enhancing immunity through autophagy. Annu. Rev. Immunol. 27; e-pub ahead of print 23 December 2008 (2009).
22. de Duve, C. & Wattiaux, R. Functions of lysosomes. Annu. Rev. Physiol. 28, 435-492 (1966).
23. Ashford, T. P. & Porter, K. R. Cytoplasmic components in hepatic cell lysosomes. J. Cell Biol. 12, 198-202 (1962).
24. Deter, R. L., Baudhuin, P. & de Duve, C. Participation of lysosomes in cellular autophagy induced in rat liver by glucagon. J. Cell Biol. 35, C11-C16 (1967).
25. Bolender, R. P. & Weibel, E. R. A morphometric study of the removal of phenobarbital-induced membranes from hepatocytes after cessation of treatment. J. Cell Biol. 56, 746-761 (1973).
26. Beaulaton, J. & Lockshin, R. A. Ultrastructural study of the normal degeneration of the intersegmental muscles of Anthereae polyphemus and Manduca sexta (Insecta, Lepidoptera) with particular reference of cellular autophagy. J. Morphol. 154, 39-57 (1977).
27. Veenhuis, M., Douma, A., Harder, W. & Osumi, M. Degradation and turnover of peroxisomes in the yeast Hansenula polymorpha induced by selective inactivation of peroxisomal enzymes. Arch. Microbiol. 134, 193-203 (1983).
28. Pfeifer, U. Inhibition by insulin of the physiological autophagic breakdown of cell organelles. Acta. Biol. Med. Ger. 36, 1691-1694 (1977).
29. Mortimore, G. E. & Schworer, C. M. Induction of autophagy by amino-acid deprivation in perfused rat liver. Nature 270, 174-176 (1977).
30. Seglen, P. O. & Gordon, P. B. 3-methyladenine: Specific inhibitor of autophagic/lysosomal protein degradation in isolated rat hepatocytes. Proc. Natl. Acad. Sci. USA 79, 1889-1892 (1982).
31. Holen, I., Gordon, P. B. & Seglen, P. O. Protein kinase-dependent effects of okadaic acid on hepatocytic autophagy and cytoskeletal integrity. Biochem. J. 284, 633-636 (1992).
32. Kang, C., You, Y. J. & Avery, L. Dual roles of autophagy in the survival of Caenorhabditis elegans during starvation. Genes Dev. 21, 2161-2171 (2007).
33. Kunz, J. Target of rapamycin in yeast, TOR2, is an essential phosphatidylinositol kinase homolog required for G1 progression. Cell 73, 585-596 (1993).
34. Blommaart, E. F., Luiken, J. J., Blommaart, P. J., van Woerkom, G. M. & Meijer, A. J. Phosphorylation of ribosomal protein S6 is inhibitory for autophagy in isolated rat hepatocytes. J. Biol. Chem. 270, 2320-2326 (1995).
35. Noda, T. & Ohsumi, Y. Tor, a phosphatidylinositol kinase homologue, controls autophagy in yeast. J. Biol. Chem. 273, 3963-3966 (1998).
36. Wullschleger, S., Loewith, R. & Hall, M. N. TOR signaling in growth and metabolism. Cell 124, 471-484 (2006).
37. Proud, C. G. Signalling to translation: How signal transduction pathways control the protein synthetic machinery. Biochem. J. 403, 217-234 (2007).
38. Huang, J. & Manning, B. D. The TSC1-TSC2 complex: A molecular switchboard controlling cell growth. Biochem. J. 412, 179-190 (2008).
39. Kim, E., Goraksha-Hicks, P., Li, L., Neufeld, T. P. & Guan, K. L. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10, 935-945 (2008)Advanced online publication.
40. Sancak, Y. et al. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320, 1496-1501 (2008).
41. Sancak, Y. et al. PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol. Cell 25, 903-915 (2007).
42. Ma, L., Chen, Z., Erdjument-Bromage, H., Tempst, P. & Pandolfi, P. P. Phosphorylation and functional inactivation of TSC2 by Erk implications for tuberous sclerosis and cancer pathogenesis. Cell 121, 179-193 (2005).
43. Gwinn, D. M. et al. AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol. Cell 30, 214-226 (2008).
44. Reggiori, F. & Klionsky, D. J. Autophagosomes: Biogenesis from scratch? Curr. Opin. Cell Biol. 17, 415-422 (2005).
45. Young, A. R. et al. Starvation and ULK1-dependent cycling of mammalian Atg9 between the TGN and endosomes. J. Cell Sci. 119 (Part 18), 3888-3900 (2006).
46. Kamada, Y., Funakoshi, T., Shintani, T., Nagano, K., Ohsumi, M. & Ohsumi, Y. Tor-mediated induction of autophagy via an Apg1 protein kinase complex. J. Cell Biol. 150, 1507-1513 (2000).
47. Suzuki, K. & Ohsumi, Y. Molecular machinery of autophagosome formation in yeast, Saccharomyces cerevisiae. FEBS Lett. 581, 2156-2161 (2007).
48. Cheong, H., Nair, U., Geng, J. & Klionsky, D. J. The Atg1 kinase complex is involved in the regulation of protein recruitment to initiate sequestering vesicle formation for nonspecifi c autophagy in Saccharomyces cerevisiae. Mol. Biol. Cell 19, 668-681 (2008).
49. Kawamata, T., Kamada, Y., Kabeya, Y., Sekito, T. & Ohsumi, Y. Organization of the pre-autophagosomal structure responsible for autophagosome formation. Mol. Biol. Cell 19, 2039-2050 (2008).
50. Hara, T. et al. FIP200, a ULK-interacting protein, is required for autophagosome formation in mammalian cells. J. Cell Biol. 181 497-510 (2008).
51. Byfield, M. P., Murray, J. T. & Backer, J. M. hVps34 is a nutrient-regulated lipid kinase required for activation of p70 S6 kinase. J. Biol. Chem. 280, 33076-33082 (2005).
52. Backer, J. M. The regulation and function of Class III PI3Ks: Novel roles for Vps34. Biochem. J. 410, 1-17 (2008).
53. Liang, X. H. Protection against fatal Sindbis virus encephalitis by Beclin, a novel Bcl-2-interacting protein. J. Virol. 72, 8586-8596 (1998).
54. Levine, B., Sinha, S. & Kroemer, G. Bcl-2 family members: Dual regulators of apoptosis and autophagy. Autophagy 4, 600-606 (2008).
55. Pattingre, S. Bcl-2 antiapoptotic proteins inhibit Beclin 1-dependent autophagy. Cell 122, 927-939 (2005).
56. Klionsky, D. J. Autophagy: From phenomenology to molecular understanding in less than a decade. Nat. Rev. Mol. Cell Biol. 8, 931-937 (2007).
57. Scherz-Shouvai, R., Shvets, E., Fass, E., Shorer, H., Gil, L. & Elazar, Z. Reactive oxygen species are essential for autophagy and specifically regulate the activity of Atg4. EMBO J. 26, 1749-1760 (2007).
58. Meijer, A. J. & Codogno, P. Signalling and autophagy regulation in health and disease. Mol. Aspects Med. 27, 411-425 (2006).
59. Wei, Y., Pattingre, S., Sinha, S., Bassik, M. & Levine, B. JNK1-mediated phosphorylation of Bcl-2 regulates starvation-induced autophagy. Mol. Cell 30, 678-688 (2008).
60. Sarkar, S. et al. Lithium induces autophagy by inhibiting inositol monophosphatase. J. Cell Biol. 170, 1101-1111 (2005).
61. Williams, A. et al. Novel targets for Huntington's disease in an mTOR-independent autophagy pathway. Nat. Chem. Biol. 4, 295-305 (2008).
62. Sarkar, S., Ravikumar, B., Floto, R. A. & Rubinsztein, D. C. Rapamycin and mTOR-independent autophagy inducers ameliorate toxicity of polyglutamine-expanded huntingtin and related proteinopathies. Cell Death. Differentiation. 16, 46-56 (2009).
63. Qing, G., Yan, P., Qu, Z., Liu, H. & Xiao, G. Hsp90 regulates processing of NF-kappaB2 p100 involving protection of NF-kappaB-inducing kinase (NIK) from autophagy-mediated degradation. Cell Res. 17, 520-530 (2007).
64. Qing, G., Yan, P. & Xiao, G. Hsp90 inhibition results in autophagy-mediated proteasome-independent degradation of IkappaB kinase (IKK). Cell Res. 16, 895-901 (2006).
65. Yu, L. et al. Autophagic programmed cell death by selective catalase degradation. Proc. Natl. Acad. Sci. USA 103, 4952-4957 (2006).
66. Nakagawa, I. Autophagy defends cells against invading group A Streptococcus. Science 306, 1037-1040 (2004).
67. Rikihisa, Y. Glycogen autophagosomes in polymorphonuclear leukocytes induced by Rickettsiae. Anat. Rec. 208, 319-327 (1984).
68. Rich, K. A., Burkett, C. & Webster, P. Cytoplasmic bacteria can be targets for autophagy. Cell Microbiol. 5, 455-468 (2003).
69. Gutierrez, M. G., Master, S. S., Singh, S. B., Taylor, G. A., Colombo, M. I. & Deretic, V. Autophagy is a defense mechanism inhibiting BCG and mycobacterium tuberculosis survival in infected macrophages. Cell 119, 753-766 (2004).
70. Birmingham, C. L., Smith, A. C., Bakowski, M. A., Yoshimori, T. & Brumell, J. H. Autophagy controls Salmonella infection in response to damage to the Salmonella-containing vacuole. J. Biol. Chem. 281 11374-11383 (2006).
71. Ling, Y. M. Vacuolar and plasma membrane stripping and autophagic elimination of Toxoplasma gondii in primed effector macrophages. J. Exp. Med. 203, 2063-2071 (2006).
72. Alonso, S., Pethe, K., Russell, D. G. & Purdy, G. E. Lysosomal killing of mycobacterium mediated by ubiquitin-derived peptides is enhanced by autophagy. Proc. Ntl. Acad. Sci. USA 104, 6031-6036 (2007).
73. Schmid, D. & Munz, C. Innate and adaptive immunity through autophagy. Immunity 27, 11-21 (2007).
74. Gutierrez, M. G. et al. Protective role of autophagy against Vibrio cholerae cytolysin, a pore-forming toxin from V. cholerae. Proc. Natl. Acad. Sci. USA 104, 1829-1834 (2007).
75. Saka, H. A., Gutierrez, M. G., Bocco, J. L. & Colombo, M. I. The autophagic pathway: A cell survival strategy against the bacterial poreforming toxin Vibrio cholerae cytolysin. Autophagy 3, 363-365 (2007).
76. Suzuki, T. et al. Differential regulation of caspase-1 activation, pyroptosis, and autophagy via Ipaf and ASC in Shigella-infected macrophages. PLoS Pathogens 3, e111 (2007).
77. Raz, E. Organ-specifi c regulation of innate immunity. Nat. Immunol. 8, 3-4 (2007).
78. Deretic, V. et al. Mycobacterium tuberculosis inhibition of phagolysosome biogenesis and autophagy as a host defence mechanism. Cell Microbiol. 8, 719-727 (2006).
79. Birmingham, C. L., Canadien, V., Kaniuk, N. A., Steinberg, B. E., Higgins, D. E. & Brumell, J. H. Listeriolysin O allows Listeria monocytogenes replication in macrophage vacuoles. Nature 451 350-354 (2008).
80. Xu, Y., Jagannath, C., Liu, X. D., Sharafkhaneh, A., Kolodziejska, K. E. & Eissa, N. T. Toll-like receptor 4 is a sensor for autophagy associated with innate immunity. Immunity 27, 135-144 (2007).
81. Delgado, M. A., Elmaoued, R. A., Davis, A. S., Kyei, G. & Deretic, V. Tolllike receptors control autophagy. EMBO J. 27, 1110-1121 (2008).
82. Shi, C. S. & Kehrl, J. H. MyD88 and Trif target Beclin 1 to trigger autophagy in macrophages. J. Biol. Chem. 283, 33175-33182 (2008).
83. Suzuki, T. & Nunez, G. A role for Nod-like receptors in autophagy induced by Shigella infection. Autophagy 4, 73-75 (2008).
84. Chen, G., Shaw, M. H., Kim, Y. G. & Nunez, G. NOD-like receptors: Role in innate immunity and infl ammatory disease. Annu. Rev. Pathol. 4, 365-398 (2009).
85. Yano, T. et al. Autophagic control of listeria through intracellular innate immune recognition in Drosophila. Nat. Immunol. 9, 908-916 (2008).
86. Sirois, C. M., Hornung, V. & Latz, E. "Toll2008" outgrows its name. Nat. Immunol. 10, 7-10 (2009).
87. Herskovits, A. A., Auerbuch, V. & Portnoy, D. A. Bacterial ligands generated in a phagosome are targets of the cytosolic innate immune system. PLoS Pathogens 3, e51 (2007).
88. Lenz, L. L., Mohammadi, S., Geissler, A. & Portnoy, D. A. SecA2-dependent secretion of autolytic enzymes promotes Listeria monocytogenes pathogenesis. Proc. Natl. Acad. Sci. USA 100 12432-12437 (2003).
89. Ratner, A. J., Aguilar, J. L., Shchepetov, M., Lysenko, E. S. & Weiser, J. N. Nod1 mediates cytoplasmic sensing of combinations of extracellular bacteria. Cell Microbiol. 9, 1343-1351 (2007 ).
90. Tattoli, I. et al. NLRX1 is a mitochondrial NOD-like receptor that amplifies NF-kappaB and JNK pathways by inducing reactive oxygen species production. EMBO Rep. 9, 293-300 (2008).
91. Ogawa, M. & Sasakawa, C. Intracellular survival of Shigella. Cell Microbiol. 8, 177-184 (2006).
92. Talloczy, Z., Virgin, H. W. & Levine, B. PKR-dependent autophagic degradation of herpes simplex virus type 1. Autophagy 2, 24-29 (2006).
93. Orvedahl, A. HSV-1 ICP34.5 confers neurovirulence by targeting the Beclin 1 autophagy protein. Cell Host Microbe 1, 23-35 (2007).
94. Lee, H. K., Lund, J. M., Ramanathan, B., Mizushima, N. & Iwasaki, A. Autophagy-dependent viral recognition by plasmacytoid dendritic cell. Science 315, 1398-1401 (2007).
95. Jounai, N. et al. The Atg5 Atg12 conjugate associates with innate antiviral immune responses. Proc. Natl. Acad. Sci. USA 104, 14050-14055 (2007).
96. Jackson, W. T. Subversion of cellular autophagosomal machinery by RNA viruses. PLoS Biol. 3, e156 (2005).
97. Nimmerjahn, F. et al. Major histocompatibility complex class II-restricted presentation of a cytosolic antigen by autophagy. Eur. J. Immunol. 33, 1250-1259 (2003).
98. Dengjel, J. Autophagy promotes MHC class II presentation of peptides from intracellular source proteins. Proc. Natl. Acad. Sci. USA 102, 7922-7927 (2005).
99. Paludan, C. Endogenous MHC class II processing of a viral nuclear antigen after autophagy. Science 307, 593-596 (2005).
100. Schmid, D., Pypaert, M. & Munz, C. Antigen-loading compartments for major histocompatibility complex class II molecules continuously receive input from autophagosomes. Immunity 26, 79-92 (2007).
101. Schmid, D., Dengjel, J., Schoor, O., Stevanovic, S. & Munz, C. Autophagy in innate and adaptive immunity against intracellular pathogens. J. Mol. Med. 84, 194-202 (2006).
102. Schmid, D. & Munz, C. Localization and MHC class II presentation of antigens targeted for macroautophagy. Methods Mol. Biol. 445 213-225 (2008).
103. Nedjic, J., Aichinger, M., Emmerich, J., Mizushima, N. & Klein, L. Autophagy in thymic epithelium shapes the T-cell repertoire and is essential for tolerance. Nature 455, 396-400 (2008).
104. Yoshimori, T. Autophagy: Paying Charon's toll. Cell 128, 833-836 (2007).
105. Miller, B. C. et al. The autophagy gene ATG5 plays an essential role in B lymphocyte development. Autophagy 4, 309-314 (2008).
106. Pua, H. H., Dzhagalov, I., Chuck, M., Mizushima, N. & He, Y. W. A critical role for the autophagy gene Atg5 in T cell survival and proliferation. J. Exp. Med. 204, 25-31 (2007).
107. Li, C. et al. Autophagy is induced in CD4+ T cells and important for the growth factor-withdrawal cell death. J. Immunol. 177 5163-5168 (2006).
108. Qu, X. et al. Promotion of tumorigenesis by heterozygous disruption of the beclin 1 autophagy gene. J. Clin. Invest. 112 1809-1820 (2003).
109. Crighton, D. et al. DRAM, a p53-induced modulator of autophagy, is critical for apoptosis. Cell 126,121-134 (2006).
110. Tasdemir, E. et al. Regulation of autophagy by cytoplasmic p53. Nat. Cell Biol. 10, 676-687 (2008).
111. Hughes, B. Anticancer drugs: Autophagy targeted in kidney cancer. Nat. Rev. Drug Discov. 7, 731 (2008).
112. Yue, Z., Jin, S., Yang, C., Levine, A.J. & Heintz, N. Beclin 1, an autophagy gene essential for early embryonic development, is a haploinsufficient tumor suppressor. Proc. Natl. Acad. Sci. USA 100, 15077-15082 (2003).
113. Lefranc, F., Facchini, V. & Kiss, R. Proautophagic drugs: A novel means to combat apoptosis-resistant cancers, with a special emphasis on glioblastomas. Oncologist 12, 1395-1403 (2007).
114. Bilir, A., Altinoz, M.A., Erkan, M., Ozmen, V. & Aydiner, A. Autophagy and nuclear changes in FM3A breast tumor cells after epirubicin, medroxyprogesterone and tamoxifen treatment in vitro. Pathobiology 69, 120-126 (2001).
115. Kroemer, G. & Jaattela, M. Lysosomes and autophagy in cell death control. Nat. Rev. Cancer 5, 886-897 (2005).
116. Gonzalez-Polo, R.A. et al. The apoptosis/autophagy paradox: autophagic vacuolization before apoptotic death. J. Cell Sci. 118, 3091-3102 (2005).
117. Scott, R.C., Juhasz, G. & Neufeld, T.P. Direct induction of autophagy by Atg1 inhibits cell growth and induces ipoptotic cell death. Curr Biol. 17, 1-11 (2007).
118. Degenhardt, K. et al. Autophagy promotes tumor cell survival and restricts necrosis, inflammation, and tumorigenesis. Cancer Cell 10, 51-64 (2006).
119. Karantza-Wadsworth, V. & White, E. Role of autophagy in breast cancer. Autophagy 3, 610-613 (2007).
120. Karantza-Wadsworth, V. et al. Autophagy mitigates metabolic stress and genome damage in mammary tumorigenesis. Genes Dev. 21, 1621-1635 (2007).
121. Lum, J.J. et al. Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell 120, 237-248 (2005).
122. Mathew, R. Autophagy suppresses tumor progression by limiting chromosomal instability. Genes Dev. 21, 1367-1381 (2007).
123. Amaravadi, R.K. et al. Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J. Clin. Invest. 117, 326-336 (2007).
124. Carew, J.S. et al. Targeting autophagy augments the anticancer activity of the histone deacetylase inhibitor SAHA to overcome Bcr-Abl-mediated drug resistance. Blood 110, 313-322 (2007 ).
125. Komatsu, M. Loss of autophagy in the central nervous system causes neurodegeneration in mice. Nature 441, 880-884 (2006).
126. Hara, T. Suppression of basal autophagy in neural cells causes neurodegenerative disease in mice. Nature 441, 885-889 (2006).
127. Rubinsztein, D.C., Gestwicki, J.E., Murphy, L.O. & Klionsky, D.J. Potential therapeutic applications of autophagy. Nat. Rev. Drug Discov. 6, 304-312 (2007).
128. Levine, B. & Kroemer, G. Autophagy in the pathogenesis of disease. Cell 132, 27-42 (2008).
129. Martinez-Vicente, M. & Cuervo, A.M. Autophagy and neurodegeneration: when the cleaning crew goes on strike. Lancet Neurol. 6, 352-361 (2007 ).
130. Ravikumar, B., Imarsilo, S., Sarkar, S., O'Kane G.J. & Rubinsztein, D.C. Rab5 modulates aggregation and toxicity of mutant huntingtin through macroautophagy in cell and fly models of Huntington disease. J. Cell Sci. 121, 1649-1660 (2008).
131. Ravikumar, B., Duden, R. & Rubinsztein, D.C. Aggregate-prone proteins with polyglutamine and polyalanine expansions are degraded by autophagy. Hum. Mol. Genet. 11, 1107-1117 (2002).
132. Ravikumar, B. et al. Inbition of mTOR induces autophagy and reduces toxicity of polyglutamine expansions in fly and mouse models of Huntington disease. Nat. Genet. 36, 585-595 (2004).
133. Shibata, M. et al. Regulation of intracellular accumulation of mutant huntingtin by beclin 1. J. Biol. Chem. 281, 14474-14485 (2006).
134. Bjorkoy, G., Lamark, T., & Johansen, T. p62/SQSTM1 forms protein aggregates degraded by autophagy and has a protective effect on Huntingtin induced cell death. J. Cell Biol. 171, 603-614 (2005).
135. Iwataa, A. et al. Increased susceptibility of cytoplasmic over nuclear polyglutamine aggregates to autophagic degradation. Proc. Natl. Acad. Sci. USA 102, 13135-13140 (2005).
136. Zatloukal, K. et al. p62 is a common component of cytoplasmic inclusions in protein aggregation diseases. Am. J. Pathol. 160 255-263 (2002).
137. Seibenhener, M. L., Geetha, T. & Wooten, M. W. Sequestosome 1/p62 - more than just a scaffold. FEBS Lett 581, 175-179 (2007).
138. Komatsu, M. et al. Homeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice. Cell 131 1149-1163 (2007).
139. Yu, W. H. et al. Macroautophagy - a novel Beta-amyloid peptide-generating pathway activated in Alzheimer's disease. J. Cell Biol. 171, 87-98 (2005).
140. Pickford, F. et al. The autophagy-related protein beclin 1 shows reduced expression in early Alzheimer disease and regulates amyloid beta accumulation in mice. J. Clin. Invest. 118, 2190-2199 (2008).
141. Sarkar, S., Krishna, G., Imarisio, S., Saiki, S., O'Kane, C. J. & Rubinsztein, D. C. A rational mechanism for combination treatment of Huntington's disease using lithium and rapamycin. Hum. Mol. Genet. 17, 170-178 (2008).
142. Sarkar, S. et al. Small molecules enhance autophagy and reduce toxicity in Huntington's disease models. Nat. Chem. Biol. 3, 331-338 (2007).
143. Fornai, F. et al. Lithium delays progression of amyotrophic lateral sclerosis. Proc. Natl. Acad. Sci. 105, 2052-2057 (2008).
144. Van Limbergen, J. et al. Definition of phenotypic characteristics of childhood-onset inflammatory bowel disease. Gastroenterology 135, 1114-1122 (2008).
145. Meinzer, U. M. et al. Ileal involvement is age dependent in pediatric Crohn's disease. Inflamm Bowel. Dis. 11, 639-644 (2005).
146. Barrett, J. C. et al. Genome-wide association defi nes more than 30 distinct susceptibility loci for Crohn's disease. Nat. Genet. 40, 955-962 (2008).
147. Kono, H. & Rock, K. L. How dying cells alert the immune system to danger. Nat. Rev. Immunol. 8, 279-289 (2008).
148. Grossmayer, G. E. Removal of dying cells and systemic lupus erythematosus. Mod. Rheumatol. 15, 383-390 (2005).
149. Qu, X. Autophagy gene-dependent clearance of apoptotic cells during embryonic development. Cell 128, 931-946 (2007).
150. Gaipl, U. S. Inefficient clearance of dying cells and autoreactivity. Curr. Top Microbiol. Immunol. 305, 161-176 (2006).
151. Duerr, R. H. et al. A genome-wide association study identifies IL23R as an inflammatory bowel disease gene. Science 314, 1461-1463 (2006).
152. Rioux, J. D. Genome-wide association study identifi es new susceptibility loci for Crohn disease and implicates autophagy in disease pathogenesis. Nat. Genet. 39, 596-604 (2007).
153. Libioulle, C. et al. A novel susceptibility locus for Crohns disease identifi ed by whole genome association maps to a gene desert on chromosome 5p13.1 and modulates the level of expression of the prostaglandin receptor EP4. PloS Genet. 3, e58 (2007).
154. Parkes, M. et al. Sequence variants in the autophagy gene IRGM and multiple other replicating loci contribute to Crohn's disease susceptibility. Nat. Genet. 39, 830-832 (2007).
155. Kugathasan, S. et al. Loci on 20q13 and 21q22 are associated with pediatric-onset inflammatory bowel disease. Nat. Genet. 40, 1211-1215 (2008).
156. Guo, B., Chang, E. Y. & Cheng, G. The type I IFN induction pathway constrains Th17-mediated autoimmune infl ammation in mice. J. Clin. Invest. 118, 1680-1690 (2008).
157. Hampe, J. et al. A genome-wide association scan of nonsynonymous SNPs identifies a susceptibility variant for Crohn disease in ATG16L1. Nat. Genet. 39, 207-211 (2007).
158. Glas, J. et al. The ATG16L1 gene variants rs2241879 and rs2241880 (T300A) are strongly associated with susceptibility to Crohn's disease in the German population. Am. J. Gastroenterol. 103, 682-691 (2008).
159. Prescott, N. J. et al. A nonsynonymous SNP in ATG16L1 predisposes to ileal Crohn's disease and is independent of CARD15 and IBD5. Gastroenterology 132, 1665-1671 (2007).
160. Van Limbergen, J. et al. Autophagy gene ATG16L1 influences susceptibility and disease location but not childhood-onset in Crohn's disease in Northern Europe. Inflamm Bowel. Dis. 14, 338-346 (2008).
161. Cadwell, K. et al. A key role for autophagy and the autophagy gene Atg16l1 in mouse and human intestinal Paneth cells. Nature 456 259-263 (2008).
162. Saitoh, T. et al. Loss of the autophagy protein Atg16L1 enhances endotoxin-induced IL-1beta production. Nature 456, 264-268 (2008).
163. Kuballa, P., Huett, A., Rioux, J. D., Daly, M. J. & Xavier, R. J. Impaired autophagy of an intracellular pathogen induced by a Crohn's disease associated ATG16L1 variant. PLos ONE 3, e3391 (2008).
164. Collazo, C. M. et al. Inactivation of LRG-47 and IRG-47 reveals a family of interferon gamma-inducible genes with essential, pathogen-specifi c roles in resistance to infection. J. Exp. Med. 194, 181-188 (2001).
165. Singh, S. B., Davis, A. S., Taylor, G. A. & Deretic, V. Human IRGM induces autophagy to eliminate intracellular mycobacteria. Science 313, 1438-1441 (2006).
166. Feng, C. G. et al. The immunity-related GTPase Irgm1 promotes the expansion of activated CD4+ T cell populations by preventing interferon-gamma-induced cell death. Nat. Immunol. 9, 1279-1287 (2008).
167. McCarroll, S. A. et al. Deletion polymorphism upstream of IRGM associated with altered IRGM expression and Crohn's disease. Nat. Genet. 40, 1107-1112 (2008).
168. Greggio, E. et al. The Parkinson disease-associated Leucine-rich repeat kinase 2 (LRRK2) is a dimer that undergoes intramolecular autophosphorylation. J. Biol. Chem. 283, 16906-16914 (2008 ).
169. Plowey, E. D., Cherralll, S. J., Liu, Y. J. & Chu, C. T. Role of autophagy in G2019S-LRRK2-associated neurite shortening in differentiated SHSY5Y cells. J. Neurochem. 105, 1048-1056 (2008).
170. Ma, A. Unresolved ER stress inflames the intestine. Cell 134 724-725 (2008).
171. Roy, C. R., Salcedo, S. P. & Gorvel, J. P. Pathogen-endoplasmic-reticulum interactions: In through the out door. Nat. Rev. Immunol. 6, 136-147 (2006).
172. Kaser, A. et al. XBP1 links ER stress to intestinal inflammation and confers genetic risk for human inflammatory bowel disease. Cell 134, 743-756 (2008).
173. Ogata, M. et al. Autophagy is activated for cell survival after endoplasmic reticulum stress. Mol. Cell Biol. 26, 9220-9231 (2006).
174. Amaravadi, R. K. & Thompson, C. B. The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin. Cancer Res. 13, 7271-7279 (2007).
175. Maiuri, M. C., Zalckvar, E., Kimchi, A. & Kroemer, G. Self-eating and self-killing: Crosstalk between autophagy and apoptosis. Nat. Rev. Mol. Cell Biol. 8, 741-752 (2007).
176. Deminoff, S. J. & Herman, P. K. Identifying Atg1 substrates: Four means to an end. Autophagy 3, 667-673 (2007).
177. Matsuda, C. et al. Therapeutic effect of a new immunosuppressive agent, everolimus, on interleukin-10 gene-defi cient mice with colitis. Clin. Exp. Immunol 148, 348-359 (2007).
178. Floto, R. A., Sarkar, S., Perlstein, E. O., Kampmann, B., Schreiber, S. L. & Rubinsztein, D. C. Small molecule enhancers of rapamycin-induced TOR inhibition promote autophagy, reduce toxicity in Huntington's disease models and enhance killing of mycobacteria by macrophages. Autophagy 3, 620-622 (2007).
179. Massey, D. C. O., Bredin, F. & Parkes, M. Use of sirolimus (rapamycin) to treat refractory Crohn's disease. Gut 57, 1294-1296 (2008).